Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1186/scrt471 http://scihub22266oqcxt.onion/10.1186/scrt471 C4097829!4097829!25158102     free     free     free Warning: file_get_contents(https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=25158102&cmd=llinks): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 215 Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Stem+Cell+Res+Ther 2014 ; 5 (4): 82 Nephropedia Template TP {{tp|p=25158102|t=2014. The mesenchymal stromal cell magic bullet finds yet another target |pdf=|usr=}}{{25158102}} gab.com Text The mesenchymal stromal cell magic bullet finds yet another target JO: Stem Cell Res Ther http://www.kidney.de/pget.php?&tw=1&pmid=25158102 #FOAvip Rojas and colleagues have presented an exciting paper demonstrating yet another relevant preclinical setting in which the mesenchymal stromal cell has a potential therapeutic application. What is particularly interesting about this study is that it addresses a disease, blood-borne systemic sepsis, which has multiple complex host responses and involves a variety of disparate organs and immune cell types. Here, the authors focus on how this injury relates more specifically to the lung, with quite dramatic improvements in several assessed injury parameters. Where does this latest demonstration of mesenchymal stromal cell efficacy leave us with regard to getting these cell therapies to the acute respiratory distress syndrome patient? Twit Text FOAVip The mesenchymal stromal cell magic bullet finds yet another target ????Stem Cell Res Ther http://www.kidney.de/pget.php?&tw=1&pmid=25158102 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=25158102 #FOAvip English Wikipedia <ref>{{Cite pmid|25158102}}</ref> The mesenchymal stromal cell magic bullet finds yet another target #MMPMID25158102 Masterson C; O?Toole D Stem Cell Res Ther 2014[]; 5 (4): 82 PMID25158102show ga Rojas and colleagues have presented an exciting paper demonstrating yet another relevant preclinical setting in which the mesenchymal stromal cell has a potential therapeutic application. What is particularly interesting about this study is that it addresses a disease, blood-borne systemic sepsis, which has multiple complex host responses and involves a variety of disparate organs and immune cell types. Here, the authors focus on how this injury relates more specifically to the lung, with quite dramatic improvements in several assessed injury parameters. Where does this latest demonstration of mesenchymal stromal cell efficacy leave us with regard to getting these cell therapies to the acute respiratory distress syndrome patient? äThe mesenchymal stromal cell magic bullet finds yet another target (epmc).pdf DeepDyve Pubget Overpricing